[Follow-up after mammary carcinoma needs to be longer. Comment to the NHG-standard 'diagnosis of mammary carcinoma'].
Lagro-Janssen
A L M
AL
Universitair Medisch Centrum St. Radboud, afd. Huisartsgeneeskunde, onderafd. Vrouwenstudies Medische Wetenschappen, Nijmegen. a.lagro-janssen@hag.umcn.nl
D001943:Breast Neoplasms / Q000175:diagnosis* / Q000628:therapy; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D009364:Neoplasm Recurrence, Local; D009426:Netherlands; D017410:Practice Guidelines as Topic; D011379:Prognosis; D012042:Registries; D013997:Time Factors